Replacing the revenue drop from losing market exclusivity on the mega
blockbuster Lipitor isn't going to be done in one fell swoop. But Pfizer
(NYSE: PFE ) may try to soften the blow by expanding its cancer franchise
through acquisition. The New York-based pharmaceutical giant is rumored to have
its eyes on Onyx Pharmaceuticals (NASDAQ: ONXX ).
No comments:
Post a Comment